Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires
N. Costedoat‐Chalumeau(Délégation Paris 5), David Isenberg(Regenerative Medicine Institute), É. Hachulla(Centre Hospitalier Universitaire de Lille), Lionel Galicier(Hôpital de la Timone), G. Gondran(Hôpital Dupuytren), J. Pouchot(Hôpital Européen Georges-Pompidou), Noël Zahr(Sorbonne Université), Sandra Navarra(University of Santo Tomas), Frédéric Houssiau(Cliniques Universitaires Saint-Luc), Gabriel Baron(Délégation Paris 5), Christian A. Pineau(Montreal General Hospital), Véronique Le Guern(Délégation Paris 5), Ricard Cervera(Hospital Clínic de Barcelona), Meenakshi Jolly(Rush University), Jean‐François Viallard(Université de Bordeaux), Gaëlle Leroux(Sorbonne Université), Peter Izmirly(New York University), Nathalie Morel(Délégation Paris 5), Francesca Dall’Ara(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), H. Bézanahary(Hôpital Dupuytren), Jill P. Buyon(New York University), Yehuda Shoenfeld(Weizmann Institute of Science), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Anǵela Tincani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Michelle Petri(Johns Hopkins University), Nancy Agmon‐Levin(Sheba Medical Center), Hanh V. Nguyen(University College London), Jean‐Charles Piette(Sorbonne Université), Guillermo Ruiz‐Irastorza(BioCruces Health research Institute), C. Deligny(Centre Hospitalier Universitaire de Martinique), Ronald van Vollenhoven(Amsterdam University Medical Centers)
Cited by 71
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857